ICMR antibody survey begins, results likely in three weeks | Latest News India - Hindustan Times
close_game
close_game

ICMR antibody survey begins, results likely in three weeks

Hindustan Times, New Delhi | By
May 25, 2020 06:18 PM IST

The cross-sectional survey of adults, aged 18 years or more, will detect infection in the community by testing for the presence of antibodies against SARS-CoV-2 that are found in the blood of people who have recovered from it.

The Indian Council of Medical Research (ICMR) has collected around 24,000 blood samples from 60 districts across 21 states over the past two weeks for a serosurvey to check for exposure to SARS-CoV-2, which causes coronavirus disease (Covid-19), among the country’s adult population.

A child wearing a protection mask and gloves is seen at Indira Gandhi International (IGI) airport, after the government allowed domestic flight services to resume, during an extended nationwide lockdown to slow the spread of the coronavirus disease (COVID-19), in New Delhi.(REUTERS)
A child wearing a protection mask and gloves is seen at Indira Gandhi International (IGI) airport, after the government allowed domestic flight services to resume, during an extended nationwide lockdown to slow the spread of the coronavirus disease (COVID-19), in New Delhi.(REUTERS)

The cross-sectional survey of adults, aged 18 years or more, will detect infection in the community by testing for the presence of antibodies against SARS-CoV-2 that are found in the blood of people who have recovered from it.

Hindustan Times - your fastest source for breaking news! Read now.

Four representative samples were collected from 60 districts on the basis of reported Covid-19 cases per million population -- zero, low (0.1-4.7), medium (4.8-10), and high (>10). Around 400 samples from 15 districts from each category were selected randomly, according to ICMR.

The first batch of about 70% of samples was dispatched to a central laboratory in Chennai for analysis on Sunday, and the results are expected in about three weeks. “The ICMR-National Institute for Research in Tuberculosis in Chennai will do the analysis,” said an ICMR official, requesting anonymity.

This community-based survey will hold the key for getting several vital clues on the viral disease such as its trend, testing pattern, etc, according to experts. “If more people have antibodies and were never detected that means the infection is widely present. It’s a good thing that only a few are suffering from complications leading to deaths. This is also an indirect methodology to ascertain whether enough tests are being conducted across the country,” said Dr. Girdhar R Babu, head, Lifecourse Epidemiology.

The blood samples will be tested for detecting IgG antibodies using ELISA method (IgG is an antibody that develops later as compared to the other antibodies, hence, determine a past infection. Elisa method is an enzyme-based laboratory test that detects and quantifies antibodies in the blood) that will determine a past infection due to the virus.

Andhra Pradesh, Assam, Bihar, Chhattisgarh, Gujarat, Jharkhand, Karnataka, Kerala, Madhya Pradesh, Maharashtra, Odisha, Punjab, Haryana, Rajasthan, Tamil Nadu, Telangana, Uttar Pradesh, Uttarakhand, Himachal Pradesh, West Bengal, and Jammu & Kashmir are the 21 states from where samples have been collected.

Besides, about 5,000 samples have been collected from 10 hot spot cities that have reported the maximum caseload such as Mumbai, Delhi, Chennai, Ahmedabad, Thane, Pune, Indore, Kolkata, Hyderabad, and Aurangabad.

“Conducting population-based serosurveillance for SARS-CoV-2 will estimate and monitor the trend of infection in the adult general population, determine the socio-demographic risk factors and delineate the geographical spread of the infection,” said a recently-published ICMR document on serosurveillance.

“Such serosurveys repeated at regular intervals can also guide containment measures in respective areas. State-specific context of disease burden, priorities and resources should guide the use of multifarious surveillance options for the current Covid-19 epidemic,” the paper said. “We’re likely to repeat the survey later depending on the results,” said the ICMR official.

Apart from the serosurvey, the Union Ministry of Health & Family Welfare (MoH&FW) has a hospital-based active surveillance plan using real-time polymerase chain reaction (RT-PCR) among healthcare workers, outpatient department patients, and pregnant women in all the districts in the country. At least 10 hospitals -- six public and four private hospitals -- will be selected from each district for the sampling, with an overall target of collecting 800 samples a month.

These two surveys are in addition to conducting a random test of about 250 severe acute respiratory infection (SARI) and influenza-like illness (ILI) cases that the Centre has advised all the states to carry out in each district.

Unveiling Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch now!

Get Current Updates on India News, Election 2024, Arvind Kejriwal News Live, Bihar Board 10th Result 2024 Live along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
  • ABOUT THE AUTHOR
    author-default-90x90

    Rhythma Kaul works as an assistant editor at Hindustan Times. She covers health and related topics, including ministry of health and family welfare, government of India.

SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Friday, March 29, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On